Skip to main content

Jung Yoon Choi

Seoul National University · 医学

研究室紹介

Professor Jung Yoon Choi's research spans molecular oncology, particularly in pediatric brain tumors such as medulloblastoma and retinoblastoma, with a focus on genomic risk stratification, treatment response, and long-term outcomes. Her work also extends to biomedical materials, including stimuli-responsive polymers like pentafluorophenyl end-capped PEG, which exhibit tunable phase transitions based on dissolved gases. Additionally, she investigates vaccine safety, especially serious adverse events following mRNA-based COVID-19 immunization, using pharmacovigilance data and predictive modeling. Her research integrates clinical oncology, molecular diagnostics, and translational biomedicine to improve patient outcomes and safety in pediatric and adult populations.

pediatric brain tumorsgenomic risk stratificationstimuli-responsive polymersvaccine safetyadverse event prediction

Research Overview

Papers
175
Total Citations
958
Papers (5y)
50
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
50total
2022
2023
2024
2025
2026
Citations per year (5y)
199total
20222023202420252026

Selected Papers

15
1
Review|62 citations·2023
Medulloblastoma: Current Perspectives and Recent Advances
Jung Yoon Choi
FWCI 17.8Brain Tumor Research and TreatmentOA

Medulloblastoma is the most common embryonal tumor of the central nervous system in childhood. Combined multimodality approaches, including surgery, radiation, and chemotherapy, have improved the outcome of medulloblastoma. Advances in genomic research have shown that medulloblastoma is not a biologically or clinically discrete entity. Previously, the risk was divided according to histology, presence of metastasis, degree of resection, and age at diagnosis. Through the development of integrated

GeneticsMedicine
2
Article|31 citations·2013
CO<sub>2</sub>‐ and O<sub>2</sub>‐Sensitive Fluorophenyl End‐Capped Poly(ethylene glycol)
Jung Yoon Choi, Jin Young Kim, Hyo Jung Moon, Min Hee Park, Byeongmoon Jeong
SJR Q1FWCI 6.2Macromolecular Rapid Communications

Pentafluorophenyl end-capped poly(ethylene glycol) (PF-PEG-PF) aqueous solution shows a lower critical solution temperature (LCST), which is sensitive to the type of gases dissolved in the solution. LCST increases from 24.5 to 26 °C when dissolved carbon dioxide is replaced by oxygen. The transparent-to-turbid transition is reversibly observed when the dissolved carbon dioxide in the PF-PEG-PF aqueous solution is exchanged with oxygen, and vice versa, at 24.5 °C. (19) F NMR and (1) H NMR spectra

Mechanical EngineeringEngineering
3
Article|27 citations·2006
Single-Nucleotide Polymorphisms and Haplotypes of Bone Morphogenetic Protein Genes and Peripheral Bone Mineral Density in Young Korean Men and Women
Jung Yoon Choi, Chan Soo Shin, Yun‐Chul Hong, Daehee Kang
SJR Q1FWCI 2.4Calcified Tissue International
Orthopedics and Sports MedicineMedicine
4
Article|22 citations·2016
Pancreas Transplantation From Living Donors: A Single Center Experience of 20 Cases
Jung Yoon Choi, Jin-Min Jung, Hyemi Kwon, Sang Hyun Shin, Y.H. Kim, Dongjin Han
SJR Q1FWCI 2.5American Journal of TransplantationOA
TransplantationMedicine
5
Article|11 citations·2019
Tandem high-dose chemotherapy with topotecan–thiotepa–carboplatin and melphalan–etoposide–carboplatin regimens for pediatric high-risk brain tumors
Jung Yoon Choi, Hyoung Jin Kang, Kyung Taek Hong, Che Ry Hong, Yun Jeong Lee, June Dong Park, Ji Hoon Phi, Seung‐Ki Kim, Kyu‐Chang Wang, Il Han Kim, Sung‐Hye Park, Young Hun Choi
SJR Q1FWCI 1.1International Journal of Clinical Oncology
GeneticsMedicine
6
Article|10 citations·2021
Effectiveness and Safety of Clofarabine Monotherapy or Combination Treatment in Relapsed/Refractory Childhood Acute Lymphoblastic Leukemia: A Pragmatic, Non-interventional Study in Korea
Jung Yoon Choi, Che Ry Hong, Kyung Taek Hong, Hyoung Jin Kang, Seongkoo Kim, Jae Wook Lee, Pil Sang Jang, Nack‐Gyun Chung, Bin Cho, Hyery Kim, Kyung‐Nam Koh, Ho Joon Im
SJR Q1FWCI 1.4Cancer Research and TreatmentOA

Remission with clofarabine was observed in approximately half of the study patients who had overall expected safety profile; however, there was no favorable long-term survival outcome in this study.

Public Health, Environmental and Occupational HealthMedicine
7
Article|8 citations·2015
Very Late Relapse of Bilateral Retinoblastoma
Jung Yoon Choi, Hyoung Jin Kang, Ji Won Lee, Hee Young Ju, Che Ry Hong, Hyery Kim, Young Suk Yu, Sung-Hye Park, Jung‐Eun Cheon, Kyung Duk Park, Hee Young Shin
SJR Q3FWCI 0.9Journal of Pediatric Hematology/Oncology

Retinoblastoma usually recurs within the first few years after treatment completion. We report a rare case of very late relapse in a 6-month-old girl who was diagnosed with bilateral retinoblastoma. The patient achieved first remission after treatment with neoadjuvant chemotherapy, enucleation of the right eye, local laser therapy of the left eye, and adjuvant chemotherapy. Extraocular relapse with multiple metastases occurred 13 years and 8 months after treatment. The patient is currently in se

OphthalmologyMedicine
8
Article|7 citations·2017
Outcomes of En Bloc Kidney Transplantation From Pediatric Donors: A Single-Center Experience
Jung Yoon Choi, Joo Hee Jung, Jae‐Hyeon Kwon, Sung Shin, Y.H. Kim, Hyuk Jai Jang, Duck Jong Han
SJR Q3FWCI 0.6Transplantation Proceedings
TransplantationMedicine
9
Article|7 citations·2024
Serious Safety Signals and Prediction Features Following COVID-19 mRNA Vaccines Using the Vaccine Adverse Event Reporting System
Jung Yoon Choi, Yongjoon Lee, Nam Gi Park, Mi Sung Kim, Sandy Jeong Rhie
SJR Q1FWCI 2.7PharmaceuticalsOA

We aimed to analyze the characteristics of serious adverse events following immunizations (AEFIs) to identify potential safety information and prediction features. We screened the individual case safety reports (ICSRs) in adults who received mRNA-based COVID-19 vaccines using the Vaccine Adverse Event Reporting System until December 2021. We identified the demographic and clinical characteristics of ICSRs and performed signal detection. We developed prediction models for serious AEFIs and identi

Infectious DiseasesMedicine
10
Review|7 citations·2007
Peritubular capillary C4d deposition and renal outcome in post‐transplant IgA nephropathy
Jung Yoon Choi, Yong Mee Cho, Won Seok Yang, Tae‐Jin Park, Jai Won Chang, Su‐Kil Park
SJR Q2FWCI 0.3Clinical Transplantation

Evidence of humoral rejection, as demonstrated by C4d(PTC) deposition, was concurrently present in significant portions of post-transplant IgAN biopsy specimens and was associated with more rapid deterioration of renal function. These results suggest that C4d(PTC) positivity needs to be determined at the time of biopsy even in cases of post-transplant glomerulonephritis and immunosuppression may need to be modified accordingly.

NephrologyMedicine
11
Article|5 citations·2020
Nitrosourea, etoposide and cyclophosphamide followed by autologous stem cell transplantation for pediatric lymphoma patients
Jung Yoon Choi, Hyoung Jin Kang, Hong Yul An, Kyung Taek Hong, Hee Young Shin
SJR Q2FWCI 0.4International Journal of HematologyOA
Pathology and Forensic MedicineMedicine
12
Article|5 citations·2020
Combination Therapy With Chemotherapy, Donor Lymphocyte Infusion With Concurrent Blinatumomab in Relapsed/Refractory Acute Precursor B-Lymphoblastic Leukemia
Ho Jung Choi, Jung Yoon Choi, Bo Kyung Kim, Hong Yul An, Kyung Taek Hong, Hee Young Shin, Hyoung Jin Kang
SJR Q3FWCI 0.3Journal of Pediatric Hematology/Oncology

The therapeutic approach for relapsed/refractory acute lymphoblastic leukemia (ALL) remains to be a challenge. The patient was diagnosed as B-cell ALL at 6 months of age and relapsed for the second time following repeat allogeneic hematopoietic stem cell transplantation (one after first complete remission [CR1] and the other after CR2). During blinatumomab monotherapy, he developed an extramedullary relapse. Finally, the combined therapy with clofarabine, donor lymphocyte infusion, and blinatumo

OncologyMedicine
13
Article|5 citations·2019
Late Recurrence of Wilms Tumor After 17 Years: A Case Report
Woo Young Park, Kyung Taek Hong, Hong Yul Ahn, Jung Yoon Choi, Hyoung Jin Kang, Sung‐Hye Park, Hee Young Shin
SJR Q3FWCI 0.3Journal of Pediatric Hematology/Oncology

Wilms tumor is the most common renal malignancy in children. Most of Wilms tumor recurrences occur within 2 years of the first diagnosis. Relapse after 5 years after the first diagnosis is called "late recurrence" and is rare in Wilms tumor. There are few case reports or small series of late recurrence of Wilms tumor. Because of the rarity of late recurrence of Wilms tumor, there is no clear guideline for its management. We describe a case of late recurrence of Wilms tumor as a remote metastasis

Molecular BiologyBiochemistry, Genetics and Molecular Biology
14
Article|4 citations·2024
Novel genomic variants influencing methotrexate delayed clearance in pediatric patients with acute lymphoblastic leukemia
Jung Yoon Choi, Hoshik Kwon, Hyery Kim, Kyung Taek Hong, Youngeun Ma, Kyung‐Nam Koh, Sunmin Yun, Keon Hee Yoo, Sang Hoon Song, Ho Joon Im, Ju Han Kim, Hyoung Jin Kang
SJR Q1FWCI 2.2Frontiers in PharmacologyOA

This is the first whole-exome sequencing-based analysis of delayed MTX clearance in pediatric patients with ALL. <i>ENG</i> rs1800956 and <i>PKD1L2</i> rs16954698 were found to be potentially influential variants associated with delayed MTX clearance. These findings provide insights into HD-MTX-induced nephrotoxicity and may contribute to reducing adverse reactions through treatment modification.

Public Health, Environmental and Occupational HealthMedicine
15
Article|4 citations·2014
역사지구 내 현대건축물 디자인심의 쟁점에 관한 연구
최정윤, 박소현
대한건축학회논문집

This paper explores critical issues, generated by the design review committees in historic districts, which deal with the construction of contemporary architecture in their historic contexts. The goal is to draw implications from those issues and to propose key points for better operations of design reviews in historic districts. As for the cases, it focuses on the projects of contemporary architecture in Bukchon, Jongno-gu, Seoul since 2006. The research methods include literature reviews, on-s

Research Areas

HematologyGeneticsPublic Health, Environmental and Occupational HealthOncologyPulmonary and Respiratory MedicineSurgery

Jung Yoon Choiの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。